These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 3367085
21. Bile acid profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis. Kihira K, Shimazu K, Kuwabara M, Yoshii M, Takeuchi H, Nakano I, Ozawa S, Onuki M, Hatta Y, Hoshita T. Steroids; 1986; 48(1-2):109-19. PubMed ID: 3660436 [Abstract] [Full Text] [Related]
23. Dehydroxylation of a 7 beta-hydroxy-C27 plant sterol in rat liver. Boberg KM, Stabursvik A, Björkhem I, Stokke O. Biochim Biophys Acta; 1989 Aug 22; 1004(3):321-6. PubMed ID: 2758026 [Abstract] [Full Text] [Related]
24. [Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders]. Kondo KH, Maeda Y, Setoguchi T. Ryoikibetsu Shokogun Shirizu; 1995 Aug 22; (8):362-6. PubMed ID: 8581653 [No Abstract] [Full Text] [Related]
25. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis. Salen G, Polito A. J Clin Invest; 1972 Jan 22; 51(1):134-40. PubMed ID: 4550120 [Abstract] [Full Text] [Related]
27. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis. Salen G, Shefer S, Cheng FW, Dayal B, Batta AK, Tint GS. J Clin Invest; 1979 Jan 22; 63(1):38-44. PubMed ID: 762246 [Abstract] [Full Text] [Related]
28. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis. Dayal B, Tint GS, Greeley DN, Williams TH, Salen G. Steroids; 1983 Oct 22; 42(4):441-8. PubMed ID: 6679948 [Abstract] [Full Text] [Related]
29. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands. Koopman BJ, Wolthers BG, van der Molen JC, van der Slik W, Waterreus RJ, van Spreeken A. J Inherit Metab Dis; 1988 Oct 22; 11(1):56-75. PubMed ID: 3128689 [Abstract] [Full Text] [Related]
30. Psychiatric disorders in patients with cerebrotendinous xanthomatosis. Berginer VM, Foster NL, Sadowsky M, Townsend JA, Siegel GJ, Salen G. Am J Psychiatry; 1988 Mar 22; 145(3):354-7. PubMed ID: 3344851 [Abstract] [Full Text] [Related]
33. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S. Metabolism; 1991 Jul 22; 40(7):741-6. PubMed ID: 1908036 [Abstract] [Full Text] [Related]
34. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens. McKenna P, Morgan SJ, Bosanquet RC, Laker MF. Br J Ophthalmol; 1990 Oct 22; 74(10):629-30. PubMed ID: 2285688 [Abstract] [Full Text] [Related]
35. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis. Stahl WL, Sumi SM, Swanson PD. J Neurochem; 1971 Mar 22; 18(3):403-13. PubMed ID: 5559251 [No Abstract] [Full Text] [Related]
37. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ. Clin Chim Acta; 1983 Jun 30; 131(1-2):53-65. PubMed ID: 6883710 [Abstract] [Full Text] [Related]
38. Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. An in vivo study. Björkhem I, Fausa O, Hopen G, Oftebro H, Pedersen JI, Skrede S. J Clin Invest; 1983 Jan 30; 71(1):142-8. PubMed ID: 6848555 [Abstract] [Full Text] [Related]